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Introduction
Mitochondrial shapes range from interconnected networks to 
punctiform organelles in different cell types. Recent experi-
ments have demonstrated that the mitochondrial morphology is 
an important determinant of mitochondrial function (McBride 
et al., 2006). In fact, the mitochondrial reticulum can be rapidly 
remodeled by dynamic fi  ssion and fusion events in response to 
the physiological requirements of a cell (Chan, 2006). For ex-
ample, extensive mitochondrial fragmentation is observed dur-
ing apoptotic cell death and in hyperglycemic conditions (Frank 
et al., 2001; Yu et al., 2006).
Mitochondrial fi  ssion and fusion rely on the function of 
multiple proteins that mediate the remodeling of the outer and 
inner mitochondrial membrane (Okamoto and Shaw, 2005). In 
mammalian cells, fi  ssion requires dynamin-related protein 1 
(DRP1; Smirnova et al., 2001; Yoon et al., 2001) along with 
hFis1 (James et al., 2003; Yoon et al., 2003; Stojanovski et al., 
2004), endophilin B1/Bif-1 (Karbowski et al., 2004; Takahashi 
et al., 2005), MTP18 (Tondera et al., 2005), GDAP1 (Niemann 
et al., 2005), DAP3 (Mukamel and Kimchi, 2004), and poten-
tially other unknown proteins. Similar to other dynamins, 
DRP1 and its yeast orthologue Dnm1p contain an N-terminal 
GTPase domain, a coiled-coil middle domain involved in pro-
tein self-assembly, and a C-terminal GTPase-activating do-
main (Fukushima et al., 2001; Pitts et al., 2004; Zhu et al., 2004; 
Ingerman et al., 2005). In vitro, DRP1 forms oligomeric ringlike 
structures and tubulates liposomes in a nucleotide-dependent 
manner, suggesting that it functions directly in membrane con-
striction and/or scission (Yoon et al., 2001). In vivo, DRP1 
forms cytosolic tetramers and is recruited to defi  ned loci along 
the mitochondrial surface, which often mark sites of mitochon-
drial fi  ssion (Shin et al., 1999; Smirnova et al., 2001; Pitts 
et al., 2004; Zhu et al., 2004). The function of mitochondrial 
DRP1 puncta that are not associated with active constriction 
sites is unclear.
The recruitment of DRP1 from the cytosol to the mito-
chondrial surface is likely mediated by membrane-associated 
receptors. Three proteins—Fis1p, Mdv1p, and Caf4p—have 
been described to form a complex with Dnm1p (Mozdy et al., 
2000; Tieu et al., 2002; Cerveny and Jensen, 2003; Griffin 
et al., 2005; Karren et al., 2005; Bhar et al., 2006; Naylor 
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ynamin-related protein 1 (DRP1) plays an impor-
tant role in mitochondrial ﬁ   ssion at steady state 
and during apoptosis. Using ﬂ  uorescence recov-
ery after photobleaching, we demonstrate that in healthy 
cells, yellow ﬂ  uorescent protein (YFP)–DRP1 recycles be-
tween the cytoplasm and mitochondria with a half-time of 
50 s. Strikingly, during apoptotic cell death, YFP-DRP1 un-
dergoes a transition from rapid recycling to stable mem-
brane association. The rapid cycling phase that characterizes 
the early stages of apoptosis is independent of Bax/Bak. 
However, after Bax recruitment to the mitochondrial mem-
branes but before the loss of mitochondrial membrane 
potential, YFP-DRP1 becomes locked on the membrane, 
resulting in undetectable ﬂ  uorescence recovery. This second 
phase in DRP1 cycling is dependent on the presence of 
Bax/Bak but independent of hFis1 and mitochondrial frag-
mentation. Coincident with Bax activation, we detect a Bax/
Bak-dependent stimulation of small ubiquitin-like modiﬁ  er-1 
conjugation to DRP1, a modiﬁ  cation that correlates with the 
stable association of DRP1 with mitochondrial membranes. 
Altogether, these data demonstrate that the apoptotic 
machinery regulates the biochemical properties of DRP1 
during cell death.
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et al., 2006; Schauss et al., 2006). In mammalian cells, only 
the outer membrane protein hFis1 has been proposed to ful-
fi  ll this function, and evidence suggests that the nature of 
this complex is rather transient (Yoon et al., 2003; Yu et al., 
2005). However, given the uniform distribution of hFis1p on 
the mitochondrial surface and the fact that its removal does 
not alter the recruitment of DRP1 to mitochondria (Lee et al., 
2004; Stojanovski et al., 2004), it is likely that other factors 
contribute to DRP1 assembly and/or function. For instance, 
sumoylation and ubiquitination were recently reported as 
poten  tial regulators of the DRP1 activity (Harder et al., 2004; 
Nakamura et al., 2006; Yonashiro et al., 2006). Components of 
the sumoylation machinery have also been reported to modu-
late the oligomerization and function of dynamin 1 (Mishra 
et al., 2004), suggesting that this posttranslational modifi  ca-
tion may control the activity of several members of the dyna-
min family of GTPases.
Recent evidence indicates that DRP1 participates in mito-
chondrial fi  ssion during apoptotic cell death (Frank et al., 
2001; Breckenridge et al., 2003; Lee et al., 2004; Germain 
et al., 2005; Parone et al., 2006). Interference with DRP1 func-
tion during apoptosis results in a block of mitochondrial fi  ssion, 
leading to long interconnected organelles, as well as a delay in 
cell death. Mitochondrial fi  ssion is an early apoptotic event, 
occurring within the same time frame as activation of the pro-
apoptotic Bcl-2 family member Bax and permeabilization of 
the mitochondrial outer membrane that leads to the release of 
multiple inner membrane space proteins and loss of the mito-
chondrial membrane potential (∆Ψ; for reviews see Heath-
Engel and Shore, 2006; Martinou and Youle, 2006). It is presently 
unclear how a fission-mediating GTPase such as DRP1 is 
integrated into this series of events. Down-regulation of DRP1 
expression by RNAi or overexpression of a dominant-negative 
mutant DRP1 K38A delays but does not block Bax recruitment 
and activation on the mitochondrial membranes and inhibits 
cytochrome c release from mitochondria (Frank et al., 2001; 
Lee et al., 2004; Neuspiel et al., 2005; Parone et al., 2006). 
This implies that both Bax and DRP1 function upstream of 
cytochrome c release in the apoptotic cascade of events, with 
DRP1 potentially participating in effi  cient Bax activation. 
  Importantly, the overexpression of DRP1 K38E blocks remodel-
ing of the mitochondrial cristae (Germain et al., 2005), an event 
that allows for the translocation of cytochrome c from the intra-
cristal stores to the intermembrane space, from where it is 
  released (Scorrano et al., 2002; Germain et al., 2005). This 
is consistent with recent data indicating that interference with 
DRP1 function does not affect the release of SMAC (second 
  mito  chondria-derived activator of caspases)/Diablo, which 
resides in the intermembrane space, but strongly inhibits the 
 release of cytochrome c that is mostly confi  ned to cristae (Arnoult 
et al., 2005; Parone et al., 2006). Whether DRP1-mediated fi  s-
sion is coupled to inner membrane remodeling or whether DRP1 
has a more direct function in cristae remodeling remains to 
be determined.
Although it has been established that the membrane re-
modeling machinery participates in apoptosis, two important 
questions remain. First, it is unclear whether the process of 
fragmentation or alterations in membrane curvature (including 
cristae remodeling) are requisite for apoptosis. Second, it 
remains unclear how the fi  ssion proteins are activated by the 
apoptotic machinery. It has been observed that mitochondria-
associated Bax coalesces at DRP1-containing fi  ssion sites and 
mitochondrial tips during cell death, implying that they may 
function together in membrane remodeling (Karbowski et al., 
2002). On the other hand, colocalization between Bax and Mfn2, 
a GTPase involved in mitochondrial fusion, may account for a 
block in fusion observed during apoptosis (Karbowski et al., 
2002). The link between the fusion machinery and Bax was re-
cently highlighted by the discovery that Bax is required for the 
regulation of Mfn2 activity and lateral assembly into foci along 
the mitochondrial tubules (Karbowski et al., 2006). Also, upon 
apoptotic stimulus, endophilin B1/Bif-1, a membrane-shaping 
protein, has been reported to interact with Bax and to control 
the recruitment and activation of both Bax and Bak, another 
Figure 1.  YFP-DRP1 rapidly cycles between 
the cytosol and preexisting sites on the mito-
chondrial membranes. (A) HeLa cells were 
transfected with YFP-DRP1 and Oct-DsRed 
(overlay). The boxed regions containing YFP-
DRP1 staining (insets) associated with mito-
chondria was photobleached (0 min), and 
ﬂ  uorescence recovery was monitored over time 
(8.5 min). Bar, 5 μm. (B) Relative ﬂ  uorescence 
intensity of YFP-DRP1 recorded during a photo-
bleaching protocol was plotted as a function of 
time (n = 7 cells). Equations used to calculate 
these parameters are described in Materials 
and methods. Error bars represent SD. (C) YFP-
DRP1 (green) localized to mitochondria labeled 
with the MitoFluor red dye (red) was photo-
bleached (0 min), and the ﬂ  uorescence recovery 
was monitored over time (5 min). Arrowheads 
indicate recovery to the same puncta.MITOCHONDRIAL DRP1 CYCLING DURING CELL DEATH • WASIAK ET AL. 441
Bcl-2–like homologue (Karbowski et al., 2004; Takahashi et al., 
2005). It is conceivable that channel-forming properties of Bax 
are actually regulated by changes in membrane shape induced 
by endophilin B1/Bif-1, although this hypothesis needs to be 
explored further.
Because the fi  ssion/fusion proteins also function at steady 
state, their properties are likely to be altered during cell death, 
allowing them to participate in membrane remodeling that is 
specifi  c for the mitochondrial apoptotic pathway. In fact, dur-
ing apoptosis, DRP1 has been shown to accumulate on mito-
chondrial tubules (Frank et al., 2001; Karbowski et al., 2002; 
Breckenridge et al., 2003; Germain et al., 2005), suggesting that 
apoptotic signals control its recruitment and/or dissociation 
from the mitochondrial membrane. However, the molecular 
details of this event are unknown. In this study, we use FRAP of 
the mitochondrial YFP-DRP1 puncta as well as biochemical 
recruitment experiments to gain insight into the cycling dynamics 
of DRP1 in healthy and apoptotic cells. The data show that the 
increased association of DRP1 with the mitochondrial mem-
branes that has been observed during apoptosis is not caused by 
an increase in the recruitment of DRP1. Instead, the membrane-
associated pool of DRP1 becomes irreversibly locked on the 
membrane during cell death in an hFis1-independent but Bax/
Bak-dependent manner. The shift from rapid cycling early in 
apoptosis to stable mitochondrial association observed after 
fragmentation is accompanied by the stable sumoylation of DRP1, 
an event that is also dependent on the presence of Bax/Bak. 
This is the fi  rst study describing specifi  c Bax/Bak-dependent 
biochemical transitions in DRP1 properties that link the induc-
tion of cell death to the initiation of changes in mitochondrial 
membrane dynamics.
Results
YFP-DRP1 cycles rapidly between 
the cytosol and preexisting sites 
on the mitochondrial membranes
In an effort to uncover the mechanisms of DRP1 association 
with mitochondrial membranes, we examined the dynamic 
properties of this event using FRAP (Fig. 1). GFP-Dnm1p has 
been shown to rescue the null mutant in Saccharomyces cerevisiae 
(Sesaki and Jensen, 1999; Legesse-Miller et al., 2003; Schauss 
et al., 2006), and fl  uorescently tagged DRP1 has been used 
extensively in worm and mammalian studies to examine the 
properties of this GTPase (Labrousse et al., 1999; Frank et al., 
2001; Smirnova et al., 2001; Harder et al., 2004; Lee et al., 
2004; Germain et al., 2005). Therefore, we constructed the 
YFP-DRP1 fusion protein and confi  rmed that it is recruited into 
punctate structures on the mitochondria similar to the endo-
genous protein (Fig. 1 A). The association of YFP-DRP1 with 
membranes is dynamic, as indicated by the effi  cient kinetics of 
FRAP (half-time = 50 s; Fig. 1 B). The cytosol rather than mito-
chondrial membranes constitutes the major supplier of un-
bleached fl  uorophores because the recovery is observed even 
when entire organelles are photobleached (unpublished data). 
The recovery of YFP-DRP1 fl  uorescence to the mitochondria is 
limited to  80%, indicating that a portion of the membrane-
associated protein cannot be replaced by unbleached molecules 
(Fig. 1 B). This immobile DRP1 population may represent a 
scaffold that is stably associated with the mitochondrial mem-
brane. Consistent with this, we occasionally notice fl  uorescence 
recovery to the same puncta, suggesting that at least a portion of 
DRP1 is recruited to predetermined sites (Fig. 1 C). The small 
Figure 2.  The in vitro recruitment of recombinant DRP1 is not enhanced during apoptosis. (A) Cytosolic and mitochondrial fractions puriﬁ  ed from sHeLa cells 
treated with DMSO or STS for 2 h were subjected to SDS-PAGE, transferred to nitrocellulose, and blotted with antibodies against DRP1 and cytochrome c 
(cyt c; left). Mitochondrial fractions were incubated at 37°C with the MitoFluor dye to monitor the presence of mitochondrial ∆Ψ (right). (B) Mitochondrial 
fractions characterized in A were incubated with cytosol and GST-DRP1 for 1 h at the indicated temperatures. After the incubation, the reactions were 
centri  fuged through a sucrose cushion to recover membranes, which were subsequently resolved by SDS-PAGE. Western blots revealed that GST-DRP1 and 
Tom20 associated with pelleted mitochondrial fractions. (C) Mitochondrial fractions puriﬁ  ed from sHeLa cells treated with DMSO or STS for 4 h were sub-
jected to SDS-PAGE, transferred to nitrocellulose, and blotted with antibodies against DRP1, cytochrome c (cyt c), and Tom20 (left). The same membrane 
fractions were incubated at 37°C with the MitoFluor red dye to monitor the presence of mitochondrial ∆Ψ (right). (D) Mitochondrial fractions characterized 
in C were incubated at 37°C with cytosol puriﬁ  ed from DMSO or STS-treated cells expressing GFP or YFP-DRP1. The reactions were centrifuged through a 
sucrose cushion to recover membrane-associated proteins, which were subsequently resolved by SDS-PAGE. Western blots revealed that YFP-DRP1 and 
Tom20 associated with mitochondrial fractions.JCB • VOLUME 177 • NUMBER 3 • 2007  442
size of the YFP-DRP1 puncta combined with the high mobility 
of the organelles complicates quantitative analysis of the fre-
quency of recovery to the same puncta, although it is clear that 
many of these sites are conserved during the bleaching and 
recovery process.
In vitro recruitment of the recombinant 
DRP1 to mitochondrial membranes 
is not enhanced during apoptosis
Biochemical fractionation and immunofl  uorescence experiments 
indicate that DRP1 accumulates on mitochondrial membranes 
during apoptosis (Fig. 2, A and C; Frank et al., 2001; Kar  bowski 
et al., 2002; Breckenridge et al., 2003; Germain et al., 2005). 
However, it has not been demonstrated whether this  accumulation 
is caused by increased recruitment of DRP1 from the cytosol or 
stabilization of existing membrane-associated DRP1 complexes. 
To explore this question, we performed in vitro recruitment 
  experiments using mitochondria-enriched membrane fractions 
purifi  ed from untreated or staurosporin (STS)-treated suspension 
HeLa (sHeLa) cells (Fig. 2). Purifi   ed mitochondria retained 
 cytochrome  c (Fig. 2, A and C) and maintained ∆Ψ, as revealed 
by the accumulation of a potential-sensitive dye, MitoFluor 
red (Fig. 2, A and C). As expected, mitochondria isolated from 
apoptotic cells contained higher levels of DRP1 on the mem-
brane (Fig. 2, A and C; Frank et al., 2001; Karbowski et al., 2002; 
Breckenridge et al., 2003; Germain et al., 2005). Experiments 
were performed in the presence of nontreated cytosol or cytosol 
purifi  ed from apoptotic cells to ensure that accessory factors 
  potentially necessary for DRP1 recruitment were present in the re-
action mix. Purifi  ed GST-DRP1 was recruited to the mitochondrial 
membranes in a temperature-sensitive manner, confi  rming the 
specifi  city of the reaction (Fig. 2 B). Surprisingly, in vitro, the 
capacity of apoptotic mitochondria to recruit GST-DRP1 was 
comparable with that of the nontreated mitochondria (Fig. 2 B). 
Similar results were obtained using cytosol from sHeLa cells 
  expressing YFP-DRP1 as a source of the recombinant protein 
and mitochondrial fractions purifi  ed from cells that have been 
treated with STS for longer periods of time (Fig. 2, C and D). 
Thus, accumulation of DRP1 on the   mitochondrial membrane 
during apoptosis is not caused by an increase in the intrinsic 
  capacity of mitochondria to recruit DRP1 from cytosol.
YFP-DRP1 ﬂ  uorescence recovery 
to mitochondrial membranes 
is inhibited during apoptosis
Next, we assessed the cycling properties of YFP-DRP1 during 
apoptosis in vivo using FRAP. As reported previously, we 
noticed an accumulation of DRP1 on the mitochondrial mem-
branes during apoptosis (Frank et al., 2001; Breckenridge et al., 
2003), resulting in puncta that appear larger and brighter 
(compare Fig. 1 A with Fig. 3, A and C). Strikingly, we observed 
a complete block in the fluorescence recovery of YFP-
DRP1 in HeLa cells treated with STS or anti-Fas–activating 
antibodies (Fig. 3). In fact, the mobile fraction of membrane-
associated YFP-DRP1 decreased abruptly from 80 ± 15% in 
nontreated cells to 12 ± 5% in STS- and anti-Fas–treated cells 
(compare Fig. 1 B with Fig. 3, B and D). Thus, in apoptotic cells, 
YFP-DRP1 puncta appear very stable and are not subjected to 
rapid turnover, as observed in the steady state. Based on the 
biochemical recruitment experiments (Fig. 2) and on the FRAP 
Figure 3.  YFP-DRP1 ﬂ  uorescence recovery to mito-
chondrial membranes is inhibited during apoptosis. 
(A and C) HeLa cells cotransfected with YFP-DRP1 and 
Oct-DsRed (overlay) were treated with STS or with 
anti-Fas–activating antibodies for the indicated amounts 
of time. The boxed regions (insets) were photobleached 
(0 min), and ﬂ   uorescence recovery was monitored 
over time (5 min). (B and D) Relative ﬂ  uorescence in-
tensity of YFP-DRP1 recorded during a photobleaching 
protocol was plotted as a function of time. FRAP curves 
from16 cells treated with STS for 90–240 min (B) and 
from 15 cells treated with anti-Fas antibodies for 180–
315 min (D) were used to generate mean plots. Error 
bars represent SD. Bar, 5 μm.MITOCHONDRIAL DRP1 CYCLING DURING CELL DEATH • WASIAK ET AL. 443
data, we conclude that DRP1 recruited during cell death be-
comes irreversibly locked on the membrane, eventually leading 
to the saturation of membrane-associated loci and an overall 
block in cycling.
To position the block in DRP1 cycling in the series of 
apoptotic events, we plotted the maximal values of fl  uorescence 
recovery from 42 cells as a function of time after STS treatment 
(Fig. 4 A). The data revealed that the block in cycling is a rela-
tively synchronous event within the total population of cells. 
Photobleaching of YFP-DRP1 showed that 85% of cells treated 
from 0 to 70 min with STS displayed a maximal fl  uorescence 
recovery to mitochondrial puncta. There was much more vari-
ability between 70 and 110 min of STS treatment, with some 
cells recovering to 95% but others showing a sharp decrease of 
fl  uorescence recovery to only 10% of the prebleach levels. After 
120 min of STS treatment, the recovery was reduced to <35% of 
prebleach levels of YFP-DRP1. In addition, examination of the 
videos from these 42 photobleaching experiments   revealed that 
YFP-DRP1 fl  uorescence recovered to mitochondria undergoing 
fi  ssion (Fig. 4, B and B′; and Video 1, available at http://www
.jcb.org/cgi/content/full/jcb.200610042/DC1). Thus, actively 
cycling DRP1 participates in fi  ssion during apoptosis-induced 
fragmentation. Conversely, fl  uorescence recovery of YFP-DRP1 
was blocked in cells displaying fragmented and immotile mito-
chondria (Fig. 4, C and C′; and Video 2). The mitochondrial ∆Ψ 
was maintained in these cells, as indicated by the mitochondrial 
accumulation of MitoFluor red (Fig. 4 C′). Altogether, these data 
indicate that the block in YFP-DRP1 cycling occurs after mito-
chondrial fragmentation but before the loss of ∆Ψ.
To position the block in DRP1 recycling relative to cyto-
chrome c release, we fi  xed HeLa cells at 0, 30, 60, 90, 120, 
150, and 180 min after STS treatment and immunostained with 
anti–cytochrome c antibodies. The percentage of cells displaying 
cytochrome c release from the mitochondria was scored, and the 
data were directly compared with the time course of maximal 
fl  uorescence recovery of YFP-DRP1 (Fig. 4 A). The release 
of cytochrome c was observed only in 10% of cells at the time 
when DRP1 becomes trapped on the mitochondrial membrane 
(80–100 min after STS treatment). This indicates that the transi-
tion in DRP1 cycling occurs before outer membrane permeabili-
zation, supporting the data obtained from live cells demon strating 
that the transition precedes the loss of ∆Ψ. Finally, the transition 
did not require caspase activity because the general caspase in-
hibitor z-Val-Ala-Asp(OMe)-fl  uoromethyl ketone (zVAD-fmk; 
or the caspase 3 inhibitor V) did not affect the transition in DRP1 
cycling, only inhibiting events downstream of outer mitochon-
drial membrane permeabilization (Figs. 3 and 4).
hFis1 is not required for DRP1 recycling 
at steady state and during apoptosis
The aforementioned data indicate that YFP-DRP is actively 
cycling during apoptotic fragmentation. To test whether frag-
mentation is mechanistically required for changes in DRP1 as-
sociation with the membrane, we blocked mitochondrial fi  ssion 
by silencing hFis1 using a siRNA approach. The knockdown 
was confi  rmed by Western blotting and indirect immunofl  uo-
rescence (Fig. 5 A). We then transfected hFis1 siRNA-treated 
cells with YFP-DRP1 and performed photobleaching studies on 
cells either untreated (n = 10) or treated with STS for >150 min 
(n = 10). In untreated hFis1-silenced cells, YFP-DRP1 fl  uores-
cence recovered within the same time frame as in wild-type (WT) 
cells (compare Fig. 1 B with Fig. 5, B and C), which is consistent 
with previous evidence that hFis1 is not required for the   recruitment 
of DRP1 at the steady state (Lee et al., 2004; Stojanovski 
et al., 2004). Upon treatment with STS, we noticed a block 
in YFP-DRP1 recovery comparable with WT cells (compare 
Figure 4.  The apoptotic block in YFP-DRP1 cycling occurs 
after fragmentation but before the loss of mitochondrial mem-
brane potential. (A) Scatter plot representing maximal ﬂ  uores-
cence recovery recorded during a FRAP protocol in 42 cells 
expressing YFP-DRP1 as a function of time of treatment with 
STS (blue diamonds). Pink circles represent the percentage of 
cells showing cytosolic cytochrome c as determined by indi-
rect immunoﬂ  uorescence at different times of STS treatment. 
Values are means of three independent experiments. Error 
bars represent SD. (B) A FRAP plot from a cell treated for 100 
min with STS expressing YFP-DRP1 (green) and Oct-DsRed 
(red; B′). Mitochondria display a characteristic beads-on-a-
string appearance, indicating active fragmentation (B′ and 
Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200610042/DC1). (C and C′) A FRAP plot (C) from a 
cell treated for 120 min with STS expressing YFP-DRP1 and 
Oct-DsRed (green; C′). Fragmented mitochondria are labeled 
with MitoFluor red (red), indicating the presence of ∆Ψ (C′). 
Video 2 illustrates the lack of mitochondrial movement after 
fragmentation. Bar, 5 μm.JCB • VOLUME 177 • NUMBER 3 • 2007  444
Fig. 3 B with Fig. 5, B and C). Interestingly, given that hFis1 in-
hibits mitochondrial fragmentation, the transition in YFP-DRP1 
cycling was observed upon mitochondria that remained highly 
tubulated (7/10 photobleached cells; Fig. 5 B, STS overlay). The 
remaining three cells displayed an arrest in YFP-DRP1 cycling on 
partially fragmented mitochondria. This delayed fragmentation 
is likely caused by residual hFis1 present in RNAi-treated cells, 
as the silencing effi  ciency was  70–80%. Together, these data in-
dicate that fragmentation events that precede the trapping of DRP1 
on the membrane are not required for the transition to occur and 
that hFis1 is not involved in the mechanisms that stabilize the 
mitochondrial association of DRP1.
The arrest in YFP-DRP1 cycling 
correlates with Bax translocation 
to the mitochondrial membrane 
and is Bax/Bak dependent
Because hFis1, a known component of the mitochondrial fi  s-
sion machinery, was not required for the stable association of 
DRP1 with mitochondria during cell death, we examined the 
potential role of the apoptotic machinery in this transition. Bax 
translocation from the cytosol to the mitochondrial membrane 
is an early apoptotic event that correlates with mitochondrial 
fragmentation and cytochrome c release (Frank et al., 2001; 
Karbowski et al., 2002; Germain et al., 2005). To determine 
when the cycling of DRP1 is altered relative to Bax translocation, 
we cotransfected CFP-Bax and YFP-DRP1 and monitored 
DRP1 cycling by FRAP before, during, and after STS-stimulated 
Bax translocation (Fig. 6). As soon as Bax puncta became 
detectable on the mitochondria, we observed colocalization 
between CFP-Bax and YFP-DRP1 as reported previously (Fig. 6, 
B′ and C′; Karbowski et al., 2002). YFP-DRP1 recovery at 
that time was comparable with that of untreated cells (Fig. 6 B). 
However, as Bax puncta on the mitochondria became more 
prominent, we noticed a sharp drop in the fl  uorescence recovery 
of YFP-DRP1 (Fig. 6 C). We grouped the results from multiple 
bleaching experiments into two categories: the fi  rst one exam-
ined the recycling of YFP-DRP1 in STS-treated cells displaying 
a cytosolic distribution of CFP-Bax (n = 9), and the second one 
regrouped apoptotic cells showing the mitochondrial recruit-
ment of CFP-Bax (n = 17). As indicated in Fig. 6 D, the recov-
ery of YFP-DRP1 in apoptotic cells with cytosolic CFP-Bax 
was comparable with untreated cells. In contrast, the block in 
YFP-DRP1 recycling was clearly observed in STS-treated cells 
in which CFP-Bax was mitochondrial (Fig. 6 D). Thus, the 
block in cycling of YFP-DRP1 correlates with Bax transloca-
tion to the mitochondria.
To determine whether the proapoptotic proteins Bax and 
Bak are necessary for the transition in DRP1 cycling, we moni-
tored the fl  uorescence recovery of YFP-DRP1 in WT or Bax/
Bak double knockout (DKO) baby mouse kidney (BMK) cells 
(Degenhardt et al., 2002). As observed by FRAP, the mobility of 
YFP-DRP1 in nontreated BMK DKO cells was comparable 
with that in WT cells, suggesting that Bax and Bak are not nec-
essary for normal DRP1 cycling (unpublished data). To assess 
YFP-DRP1 cycling properties during apoptosis, STS treatment 
periods longer than 3 h were chosen to ensure that most cells 
were past the transition point mapped in Fig. 4 A. As expected, 
the fl  uorescence recovery of YFP-DRP1 was drastically reduced 
in apoptotic BMK WT cells, similar to HeLa cells (Fig. 7 A, 
left; and quantifi  cation in B). However, the kinetics of fl  uores-
cence recovery in BMK DKO cells were comparable with those 
in nonapoptotic cells, indicating that Bax/Bak are required for 
the block in DRP1 cycling (observed recovery in STS-treated 
Figure 5.  hFis1 is not required for YFP-DRP1 recycling 
at steady state or during apoptosis. (A) Control or 
speciﬁ  c siRNAs were used to silence the expression of 
hFis1 in HeLa cells, as shown by Western blotting and 
by indirect immunoﬂ   uorescence with antibodies di-
rected against hFis1. Antibodies against Hsp60 were 
used as a loading control (top). (B) hFis1 siRNA–
treated Hela cells transfected with YFP-DRP1 were un-
treated or treated with 1 μM STS for >150 min. The 
overlay shows YFP-DRP1 (green) and a mitochondrial 
staining with MitoFluor red (red). Note the inter-
connected mitochondrial tubules in STS-treated cells. 
The boxed regions (insets) were photobleached (0 min), 
and ﬂ   uorescence recovery was monitored over time 
(2 min). Bars, 5 μm. (C) Relative ﬂ  uorescence intensity 
of YFP-DRP1 recorded during the photobleaching protocol 
was plotted as a function of time. FRAP curves from 
hFis1 siRNA–treated cells incubated with control media 
(n = 9) or with media containing STS for 150–250 
min (n = 10) were used to generate mean plots. Error 
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DKO cells is  80%, as in control cells [Fig. 1 B], with a half-
time of 55 vs. 50 s in control cells; Fig. 1 B).
By subcellular fractionation, the association of DRP1 
with mitochondrial membranes was similar in nontreated WT 
and DKO cells, confi  rming that at steady state, Bax and Bak do 
not modulate the membrane-binding properties of DRP1  (Fig. 
8 A). Conversely, the increased membrane association of DRP1 
characteristic of apoptotic WT cells was not detected in DKO 
cells, indicating that Bax/Bak are required for the stabilization 
of DRP1 on the mitochondrial membrane (Fig. 8 A).
DRP1 is sumoylated during apoptosis 
in a Bax/Bak-dependent manner
The apoptotic stimulus not only induced a stable membrane-
associated form of DRP1 but also promoted the appearance of a 
high molecular weight DRP1-reactive band in cytosolic and 
mitochondrial fractions isolated from BMK cells (Fig. 8 A). 
Strikingly, the emergence of this high molecular weight species 
was absolutely dependent on the presence of Bax/Bak, as it was 
absent from STS-treated DKO cells (Fig. 8 A). We previously 
reported that DRP1 is transiently conjugated to small ubiquitin-
like modifi  er-1 (SUMO-1) at steady state in COS-7 cells, result-
ing in the presence of a substoichiometric 150-kD band (Harder 
et al., 2004). In the present study, we also detected DRP1 conju-
gates at steady state in BMK cells (Fig. 8 A, cytosol; long expo-
sure), and the absence of Bax/Bak did not affect the overall pattern 
of these substoichiometric conjugates. To determine whether 
the apoptotic-induced Bax/Bak-dependent band was indeed the 
result of an increase in sumoylation, we immunoprecipitated 
DRP1 from BMK cell extracts treated or untreated with STS. 
Figure 6.  The arrest in YFP-DRP1 cycling correlates with Bax translocation 
to the mitochondrial membrane. (A–C) HeLa cells coexpressing YFP-DRP1 
and CFP-Bax were treated with STS for 20–120 min before photobleach-
ing. The distribution of CFP-Bax in a representative cell is documented on 
the left, whereas the ﬂ  uorescence recovery of YFP-DRP1 in the same cell is 
shown on the right. Insets (A′–C′) show colocalization between YFP-DRP1 
(red) and CFP-Bax (green). The dotted lines in A and B show the outlines of 
one cell. (D) Averaged FRAP curves showing the cycling of YFP-DRP1 in 
cells displaying the cytosolic (triangles; n = 11) or mitochondrial (squares; 
n = 17) distribution of CFP-Bax treated with STS for 20–120 min. Error 
bars represent SD.
Figure 7.  The block in cycling of YFP-DRP1 during apoptosis is Bax/Bak 
dependent. (A) Wild-type (WT) and Bax/Bak double knockout (DKO) BMK 
cells were transfected with YFP-DRP1 and treated with STS for 195–365 
min before photobleaching. The boxed regions containing YFP-DRP1 (green) 
associated with mitochondria (red) was photobleached (0 min), and ﬂ  uo-
rescence recovery was monitored over time (4.5 min; insets). Bar, 5 μm. 
(B) Averaged FRAP curves showing the cycling of YFP-DRP1 in WT (dia-
monds; n = 12) and Bax/Bak knockout cells (DKO; squares; n = 14) 
treated with STS for 195–365 min. Error bars represent SD.JCB • VOLUME 177 • NUMBER 3 • 2007  446
The DRP1-reactive 150-kD band detected in the immunoprecipi-
tates was indeed labeled by anti–SUMO-1 antibodies, confi  rming 
its identity as a DRP1–SUMO-1 conjugate (Fig. 8 B).
To confi  rm the involvement of sumoylation during apoptosis-
induced mitochondrial fragmentation, we determined the local-
ization of YFP–SUMO-1 in live HeLa cells treated with STS. 
We have previously observed YFP–SUMO-1 association with 
mitochondria under steady-state conditions (Harder et al., 2004). 
However, given the lability and substoichiometric amounts of the 
conjugate at steady state, this is not easily detectable. Strikingly, 
upon the stimulation of cell death, YFP–SUMO-1 was readily 
observed to accumulate at sites of mitochondrial constriction 
and at mitochondrial tips (Fig. 8 C). This accumulation was 
observed during active apoptotic fragmentation as well as after 
fragmentation (Fig. S2, available at http://www.jcb.org/cgi/
content/full/jcb.200610042/DC1). In addition, we observed par-
tial colocalization between mitochondria-associated endogenous 
DRP1 and YFP–SUMO-1 during apoptotic death (Fig. 8 D). 
The lack of YFP–SUMO-1 from some DRP1-positive puncta 
likely refl  ects the transitory and substoichiometric nature of this 
posttranslational modifi  cation (as demonstrated in biochemical 
fractionation experiments; Fig. 8 A). Interestingly, the absence 
of DRP1 from some YFP–SUMO-1–positive puncta indicates 
the existence of additional mitochondrial SUMO-1 substrates as 
previously reported (Harder et al., 2004).
Finally, we wanted to examine whether the stable sumoylation 
of DRP1 was specifi  c for apoptosis or whether this conjugation 
event was common to other treatments that induce nonapoptotic 
mitochondrial fragmentation or remodeling. As expected, treat-
ment of BMK cells with STS induced the DRP1 conjugate, whereas 
incubation with carbonyl cyanide m-chlorophenylhydrazone 
or oligomycin (Legros et al., 2002; De Vos et al., 2005) did 
not trigger the appearance of high molecular weight DRP1 bands 
(Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb
.200610042/DC1). Together, these data demonstrate that the 
 sumoylation of DRP1 is specifi  cally stimulated during apo ptosis 
in a manner dependent on Bax/Bak.
Discussion
In mammalian cells, the assembly dynamics of the mitochon-
drial fi  ssion complex are unknown. In this study, we document 
the cycling properties of DRP1 at steady state and during apop-
totic death. Using FRAP, we demonstrate that the cytosolic 
DRP1 protein binds reversibly to membranes in healthy cells. Its 
cycling kinetics are comparable with those of human dynamin 2 
at the centrosome (half-time = 60 s; Thompson et al., 2004). 
Interestingly, the yeast orthologue of DRP1, Dnm1p, was shown 
to recycle in a slow and ineffi  cient manner, which may refl  ect 
important differences in the mechanisms of recruitment and 
retention of these two proteins (Legesse-Miller et al., 2003). 
Association of DRP1 with mitochondrial membranes appears 
more stable than that of many other proteins recruited to intra-
cellular membranes. For example, examination of multiple 
Figure 8.  DRP1 is sumoylated during apo  p-
tosis in a Bax/Bak-dependent manner. (A) Mito-
chondrial and cytosolic fractions puriﬁ  ed from 
BMK wild-type (WT) or Bax/Bak double knock-
out (DKO) cells treated with DMSO or STS for 
4 h were subjected to SDS-PAGE, transferred 
to nitrocellulose, and blotted with antibodies 
against DRP1 and cytochrome c (cyt c), Bax, 
and Hsp60. Long exposure reveals a 150-kD 
band recognized by the anti-DRP antibody. 
(B) Total lysates from BMK WT and DKO cells 
were subjected to immunoprecipitation with to-
tal mouse IgG or anti-DRP1 antibodies. Speci-
ﬁ   cally bound proteins were resolved by 
SDS-PAGE, transferred to nitrocellulose, and 
blotted with antibodies against DRP1 and 
SUMO-1. Input represents 5% of the total ly-
sate used for immunoprecipitation. Closed arrow-
heads point to bands at 150 kD that are 
immunoreactive for both DRP1 and SUMO-1. 
Open arrowhead points to the monosumoyl-
ated DRP1. (C, i and ii) HeLa cells were trans-
fected with YFP–SUMO-1 and treated with STS 
from 95 to 205 min. YFP–SUMO-1–positive 
puncta (red; left insets) were detected in asso-
ciation with mitochondria labeled with MitoFluor 
red (green; middle insets), often at potential 
ﬁ   ssion sites (right insets). The insets show 
magniﬁ  cations of the boxed regions. The left 
inset is a grayscale image of the YFP–SUMO-1 
channel (shown in green in the overlay in the 
right inset), and the middle inset shows a gray-
scale image of the Mitoﬂ  uor red channel (indi-
cated in red in the overlay in the right inset). 
Note the presence of YFP–SUMO-1 at the sites of mitochondrial constriction. (D, i and ii) HeLa cells transfected with YFP–SUMO-1 (red) were treated with 
STS for 2 h, ﬁ  xed, and immunostained with antibodies against Tom20 (blue) and DRP1 (green). YFP–SUMO-1 puncta associated with mitochondria are 
  observed to colocalize (solid circles) or not colocalize (dotted circles) with DRP1. Bars (C), 5 μm; (D) 1 μm.MITOCHONDRIAL DRP1 CYCLING DURING CELL DEATH • WASIAK ET AL. 447
components of the exocyst machinery in yeast revealed two 
separate classes of proteins: those with time constants ranging 
from 12 to 23 s (Sec4p, Sec5p, Sec6p, Sec8p, Sec10p, Sec15p, 
and Exo84p) and those with a time constant of  60 s (Sec3p 
and Exo70p; Boyd et al., 2004). Coated vesicle components 
GGA1, clathrin, COPI, and Arf1 have been reported to recycle 
with half-times of recovery of  10–35 s (Wu et al., 2001; Presley 
et al., 2002; Puertollano et al., 2003). Therefore, the cycling 
kinetics of DRP1 is slower compared with other membrane-
associated protein complexes. Interestingly, we also observed 
that the fl  uorescence recovery of DRP1 often occurred at pre-
existing sites, indicating that DRP1 or its mitochondrial recep-
tors generate stable membrane domains.
Several lines of evidence indicate that DRP1 plays an im-
portant role in the effi  cient progression of apoptosis (for review 
see Martinou and Youle, 2006). However, mechanisms that are 
responsible for regulation of the mitochondrial fi  ssion machin-
ery during cell death are unknown. In this study, we defi  ne two 
phases of DRP1 cycling during apoptosis. The fi  rst phase is 
characterized by active DRP1 cycling and is independent of 
Bax/Bak, whereas the second phase is characterized by a stable 
membrane association of DRP1 that is Bax/Bak dependent. The 
combined biochemical and FRAP data suggest that the mito-
chondrial accumulation of DRP1 observed during the second 
phase results from stabilization of the membrane-bound protein 
rather than the stimulation of DRP1 recruitment (Frank et al., 
2001; Breckenridge et al., 2003; for review see Martinou and 
Youle, 2006). This change in DRP1 properties occurs after Bax 
translocation to the membrane and depends on the presence of 
Bax/Bak, revealing that DRP1 not only functions downstream 
of Bax but that DRP1 cycling is regulated by Bax.
There are several mechanisms through which Bax/Bak 
could affect the membrane binding of DRP1. After the induc-
tion of apoptosis, Bax-positive puncta appear at fi  ssion sites, 
where they colocalize with DRP1 just before the block in 
  cycling (Fig. 6). Therefore, Bax recruitment and oligomerization 
at DRP1 foci may directly or indirectly induce a shift in DRP1 
cycling dynamics and promote its stable association with mem-
branes. Interestingly, a BAR (Bin/amphiphysin/Rvs) domain–
containing fi  ssion protein, endophilin B1/Bif-1, is known to 
bind to Bax and was recently shown to be required for Bax acti-
vation and membrane recruitment during apoptosis (Takahashi 
et al., 2005). As endophilin B1/Bif-1 function is required up-
stream of Bax, it would also be requisite for the transition in 
DRP1 cycling. It is possible that a stabilized microdomain in-
duced by endophilin B1/Bif-1 bound to activated Bax oligomers 
may create an environment in which DRP1 is stably recruited. 
In turn, the constricting ability of DRP1 may also contribute to 
the formation of curvature within the outer membrane that is 
required for the effi  cient insertion of Bax (Basanez et al., 1999, 
2002; Annis et al., 2005). Together, the recruitment of these 
proteins would create a stable microdomain that strengthens 
itself with a positive feedback mechanism. Evidence that the 
dominant-negative DRP1 delays (but does not block) Bax acti-
vation is consistent with this idea (Neuspiel et al., 2005). In the 
absence of Bax, these microdomains would instead be dynamic 
and transient, with DRP1 rapidly cycling on and off the membrane. 
In addition, Bax may induce changes in the calcium fl  ux from 
the ER, which has been shown to be a required event for DRP1 
recruitment and cristae remodeling (Breckenridge et al., 2003; 
Germain et al., 2005). The molecular details of these pathways 
remain to be explored, but our data show a substantial Bax/
Bak-dependent transition in the nature of DRP1 puncta on the 
mitochondria during cell death.
It has been suggested that hFis1 functions as a receptor/
adaptor for DRP1 in mitochondrial fi  ssion (Yoon et al., 2003; Yu 
et al., 2005). However, the FRAP data reported here demonstrate 
that hFis1 is not required for DRP1 cycling on and off membrane 
at steady state, which is consistent with previous observations in 
mammalian cells (Lee et al., 2004). This is distinct from yeast, in 
which Fis1p appears to function both upstream and downstream 
of Dnm1p recruitment (Mozdy et al., 2000; Tieu and Nunnari, 
2000; Tieu et al., 2002; Cerveny and Jensen, 2003). Because the 
silencing of hFis1 results in a clear inhibition of mitochondrial 
fragmentation, it is more likely that hFis1 functions downstream 
of DRP1 recruitment in the fi  ssion process. This downstream 
function of hFis1 is consistent with the second requirement for 
yeast Fis1p in which, together with Mdv1p, they facilitate the 
oligomeric assembly of Dnm1p that is required to drive fi  ssion 
(Ingerman et al., 2005; Bhar et al., 2006; Naylor et al., 2006). Im-
portantly, the silencing of hFis1 does not preclude the appearance 
of the transition in YFP-DRP1 cycling during apoptosis (Fig. 5). 
This is explained by the fact that Bax and caspase 3 activation, 
although slightly reduced, is still detectable in hFis1 knockdown 
cells (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200610042/DC1; and not depicted; Parone et al., 2006).
It is important to consider the function of the Bax/Bak-
dependent stable membrane-associated form of DRP1. Our data 
indicate that the block in YFP-DRP1 cycling occurs after frag-
mentation and does not require mitochondrial fi  ssion because 
it is observed on tubulated mitochondria in the hFis1 siRNA-
treated apoptotic cells (Fig. 5). Thus, it is likely that the function 
of YFP-DRP1 that is stably associated with membranes is un-
related to its role in mitochondrial fragmentation. Another im-
portant piece of data indicates that the block in cycling occurs 
before cytochrome c release and loss of ∆Ψ. It has been shown 
that Bax oligomerization is required for permeabilization of the 
outer membrane (Antonsson et al., 2001; Annis et al., 2005) and 
that the remodeling of the inner membrane is required to facili-
tate the complete release of cytochrome c from intracristae 
stores (Scorrano et al., 2002; Germain et al., 2005; Cipolat et al., 
2006; Frezza et al., 2006). Our previous study revealed that 
DRP1 plays a role in apoptosis because it is requisite not only for 
mitochondrial fi  ssion but also for cristae remodeling (Germain 
et al., 2005). Importantly, this DRP1-dependent remodeling 
requires a functional permeability transition pore (Germain 
et al., 2005), which is consistent with the appearance of a stable 
DRP1 form before the loss of ∆Ψ (Fig. 4). This suggests that 
the apoptosis-specifi  c role for DRP1 may not reside in its ability 
to divide mitochondria but in the remodeling of both the inner 
and outer membranes that precedes the permeabilization of the 
outer membrane. Thus, we propose that during apoptosis, an 
actively cycling DRP1 mediates mitochondrial fi  ssion, whereas 
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involved in later apoptotic events, such as membrane remodeling 
that leads to the complete release of cytochrome c and eventual 
loss of ∆Ψ.
Finally, we report a correlation between the stable associ-
ation of DRP1 with the mitochondrial membranes and stimula-
tion of the sumoylation of DRP1 during cell death. Importantly, 
both events are linked in their requirement for Bax/Bak, indicat-
ing that sumoylation may stabilize the association of DRP1 
with mitochondrial membranes.
Posttranslational modifi  cation by SUMO commonly reg-
ulates the assembly and disassembly of protein complexes, 
protein localization, stability, and function (Johnson, 2004). 
Sumoylation is known to be highly substoichiometric because it 
often generates intermediates that result in new protein inter-
actions or conformational states that persist even after SUMO 
removal (Johnson, 2004). Recent studies implicate SUMO as a 
regulator of nuclear localization and/or functions of proteins 
that are involved in apoptosis (Huang et al., 2003; Besnault-
Mascard et al., 2005; Bischof et al., 2006; Hayashi et al., 2006; 
Janssen et al., 2006). In the present study, we report DRP1 as 
the fi  rst and only known mitochondrial SUMO target whose 
modifi  cation is up-regulated during apoptotic cell death. The 
detection of SUMO-positive dots associated with mitochondrial 
fi  ssion sites reinforces the notion that sumoylation plays a role 
in mitochondrial remodeling during apoptosis. Of note, the 
sumoylation of mitochondrial targets appears to be a selective 
rather than global event because overall mitochondria-associated 
sumoylation is not increased during apoptosis (unpublished 
data), indicating that specifi  c proteins are being targeted, such 
as DRP1. Although we have documented the stimulation of 
DRP1 sumoylation, we have not provided evidence that this 
modifi   cation is functionally linked to DRP1 cycling during 
apoptosis. Our efforts to investigate this question have been 
complicated by the requirement to selectively block the second 
phase of DRP1 cycling and Bax/Bak-dependent sumoylation of 
DRP1. Further analysis of the role of sumoylation in DRP1 
function during apoptosis will require a thorough characteriza-
tion of its sumoylation/desumoylation cycle and of how it regu-
lates the protein properties. Future work will focus on the 
dissection of specifi  c Bax/Bak-dependent changes in DRP1 con-
jugation and cycling dynamics and their function in apoptotic 
membrane remodeling.
Materials and methods
Antibodies
Antibodies were obtained from the following providers: α-DRP1 (BD Bio-
sciences), α-Hsp60 (Sigma-Aldrich), α–SUMO-1 (Zymed Laboratories), α-Bax 
(Upstate Biotechnology), α–cytochrome  c (BD Biosciences), mouse IgG 
(Sigma-Aldrich), α-hFis1 (Biovision), and α-Tom20 rabbit serum (gift from 
G. Shore, McGill University, Quebec, Canada).
DNA constructs
YFP-DRP1, YFP–SUMO-1, and Oct-DsRed were described previously 
(Harder et al., 2004). pECFP-C3–human Bax was constructed using the 
pAdLoxGAL4-pEGFP-C3-hBax construct (gift from R. Slack, University of 
Ottawa, Ontario, Canada).
Cell culture
HeLa and BMK WT and DKO cells (gift from E. White, Rutgers University, 
New Brunswick, NJ) were grown in DME and RPMI 1640 medium   (Invitrogen), 
respectively. sHeLa cells were maintained in F12 medium (Invitrogen) with 
0.1 mM MEM nonessential amino acids (Invitrogen). For subcellular frac-
tionation, sHeLa cells were grown in ﬂ  asks for 5–6 d in 2 liters of MEM 
for suspension culture (Sigma-Aldrich) with 10 mM Hepes, pH 7.4, and 
0.1 mM MEM nonessential amino acids. All media used were supple-
mented with 10% FBS and antibiotics.
Confocal microscopy
Cells grown on glass coverslips were transfected with LipofectAMINE 
2000 (Invitrogen) according to the manufacturer’s instructions. 16 h later, 
cells were treated with 1 μM STS (LC Laboratories) and 10 μM zVAD-fmk 
(MP Biomedicals) or with 1 μg/ml α-Fas–activating antibodies (Upstate 
Biotechnology), 40 μM caspase 3 inhibitor V (Calbiochem), and 10 μg/ml 
cycloheximide (Sigma-Aldrich). For live microscopy, cells were mounted in 
media with 20 mM Hepes, pH 7.4, and 50 nM MitoFluor red (Invitrogen) 
and were imaged at 37°C. For immunoﬂ  uorescence, cells were ﬁ  xed with 
4% PFA/PBS for 15 min, permeabilized with 0.2% Triton X-100/PBS for 
4 min, and blocked with 5% BSA, 5% FBS, and 0.02% Triton X-100 in PBS 
for 30 min at RT. Cells were labeled with primary antibodies and with goat 
α–rabbit Rhodamine X red and goat α–mouse AlexaFluor647 secondary 
antibodies (Invitrogen). Cells were visualized with a 100× NA 1.4 oil im-
mersion objective (Olympus) at 1 airy U on a laser-scanning confocal mi-
croscope (IX80; Olympus) operated by FV1000 software version 1.4a 
(Olympus). To directly compare recovery curves from different treatments, 
data were normalized to correct for variations in background ﬂ  uorescence 
(Fbkgd) and loss of ﬂ  uorescence during the bleach according to the formula 
F(t)norm = 100 × (F(t)ROI − Fbkgd)(Fi_cell − Fbkgd)/(F(t)cell − Fbkgd)(Fi_ROI − Fbkgd), 
where F(t)ROI = region of interest intensity, F(t)cell = total cell intensity at any 
given time point (t), Fi_ROI = initial intensity of the region of interest, and 
Fi_cell = initial intensity of the entire cell (Goodwin and Kenworthy, 2005). 
The resulting normalized data were then averaged for different cells, and 
the associated SD was calculated. The percent mobile fraction was calcu-
lated according to the formula Mf = 100 × (F∝ − F0)/(Fi − F0), where F∝, 
F0, and Fi are the normalized ﬂ  uorescence intensities at the asymptote, im-
mediately after the bleach, and before the bleach, respectively (Goodwin 
and Kenworthy, 2005). Maximal ﬂ  uorescence recovery at t = ∝ and half-
time of recovery were calculated using nonlinear regression (curve ﬁ  t) in 
Prism 4.03 software (GraphPad).
RNAi
Transfection of HeLa cells was performed using siGENOME SMARTpool 
transfection reagent (Dharmacon) according to the manufacturer’s proto-
col. In brief, cells were seeded at 80% conﬂ  uency in 10-cm dishes contain-
ing coverslips and transfected with either equal amounts of four siRNA 
oligonucleotides (hFis1; antisense sequences 5′-P  U  A  A  C  A  G  A  C  C  G  C  A  C  A  G-
C  U  C  C  U  U  -3′, 5′-P  U  U  A  G  A  U  A  G  U  A  C  U  G  C  A  U  G  C  C  U  U  -3′, 5′-P  U  G  A  U  G  A  A  U-
G  A  U  C  U  U  U  G  A  G  C  U  U  -3′, and 5′-P  U  G  G  C  U  G  U  U  A  A  G  C  G  U  U  U  C  U  U  U  U  -3′) 
or nontargeting sequence siRNA (glyceraldehyde-3-phosphate dehydroge-
nase) oligonucleotides. Cells were exposed to the transfection mixture for 
16 h in complete OPTI-MEM medium + 10% FBS, at which time the trans-
fection medium was replaced. 48 h after transfection, the cells were re-
transfected in the same way. 96 h after the initial transfection, cells were 
collected and analyzed for hFis1 expression. YFP-DRP1 was transfected 
16 h before analysis by indirect immunoﬂ  uorescence or by FRAP.
Subcellular fractionation
Cells treated with DMSO or 1.0–1.5 μM STS were collected by trypsiniza-
tion or centrifugation and lysed using a ball-bearing cell breaker in buffer A 
(220 mM mannitol, 68 mM sucrose, 80 mM KCl, 0.5 mM Mg[CH3COO]2, 
10 mM Hepes, pH 7.4, 2 mg/ml BSA, and protease inhibitor cocktail 
[Roche Diagnostics]). Lysates were centrifuged at 3,000 rpm for 10 min at 
4°C. The supernatant was spun at 10,000 rpm for 15 min at 4°C, yielding 
a mitochondria-enriched pellet and a light membrane fraction. Light mem-
branes were spun at 70,000 rpm for 40 min at 4°C in a TLA 100.4 rotor 
(Beckman Coulter) to yield cytosol. Equal protein amounts from each frac-
tion were analyzed by SDS-PAGE and Western blotting.
In vitro recruitment experiments
The assay was performed in a 50-μl volume with 50 μg of mitochondria 
and 50 μg of cytosol from sHeLa cells in the presence of 50–100 nM GST 
or GST-DRP1 in 110 mM mannitol, 70 mM sucrose, 80 mM KCl, 0.25 mM 
EGTA, 3 mM Mg(CH3COO)2, 15 mM Hepes, pH 7.4, 2 mM K2HPO4, 
1 mM ATP(K
+), 0.08 mM ADP, 5 mM Na succinate, 1 mM DTT, and 1 mg/ml 
BSA. Soluble components were centrifuged before the assay at 80,000 rpm 
for 30 min at 4°C in a TLA 100.4 rotor (Beckman Coulter). Reactions were 
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through 1 ml of 250 mM sucrose and 10 mM Hepes, pH 7.4, at 13,000 
rpm for 20 min at 4°C. Membrane pellets were analyzed by SDS-PAGE. To 
prepare virally expressed GFP and YFP-DRP1, sHeLa cells were infected with 
adenoviruses at 22 plaque-forming units/cell (gifts from R. Slack). 48 h later, 
cells were treated with DMSO or 1 μM STS for 4 h and lysed by sonication 
in buffer A lacking BSA. The lysate was precleared for 5 min at 13,000 
rpm, and the resulting supernatant was spun at 80,000 rpm for 40 min in a 
TLA 100.4 rotor. 10 μg of cytosol was used per recruitment reaction.
Fusion proteins
GST and GST-DRP1 were produced in an Escherichia coli BL21 strain. 
In brief, fusion proteins were induced with 0.5 mM IPTG at 22°C for 20 h. 
Bacteria were lysed in a French press in buffer B (20 mM Hepes, pH 7.4, 
100 mM NaCl, 2 mM MgCl2, 1 mM DTT, and protease inhibitors). The lysate 
was supplemented with 1% Triton X-100 and spun at 35,000 rpm for 30 min 
at 4°C in a Ti55.2 rotor (Beckman Coulter). The supernatant was incubated 
overnight with glutathione–Sepharose beads (GE Healthcare). Beads were 
washed in buffer B supplemented with 0.1% Triton X-100, and the fusion 
proteins were eluted from the beads according to a standard protocol.
Immunoprecipitation
BMK cells were treated with 1 μM STS or 0.01% DMSO for 4 h and 
scraped in 10 mM Hepes, pH 7.4, 50 mM NaCl, 2 mM Mg(CH3COO)2, 
20 mM N-ethylmaleimide, and protease inhibitor cocktail. Cells were solu-
bilized with 1% Triton X-100 and spun at 80,000 rpm in the TLA 100.4 
rotor (Beckman Coulter). Precleared supernatant was incubated overnight 
with protein G–Sepharose beads (GE Healthcare) coupled to α-DRP1 anti-
body or total mouse IgG. Speciﬁ  cally bound proteins were resolved by 
SDS-PAGE and analyzed by Western blotting.
Online supplemental material
Supplemental videos and images within the ﬁ  gures were acquired on a 
laser-scanning confocal microscope (IX80 FV1000; Olympus). HeLa cells 
were transfected overnight with YFP-DRP1 or YFP–SUMO-1 and treated 
for 1 μM STS and 10 μM zVAD-fmk, respectively. For imaging, cells were 
mounted in a chamber in DME media supplemented with 20 mM Hepes, 
pH 7.4, and 50 nM MitoFluor red (Invitrogen) at 37°C. Fig. S1 shows that 
apoptosis proceeds in cells silenced for the expression of hFis1. Fig. S2 
shows that YFP–SUMO-1 is associated with apoptotic mitochondria during 
and after fragmentation. Fig. S3 shows that the stable SUMO-1 conju-
gate of DRP1 is speciﬁ  c to apoptotic fragmentation. Videos 1 and 2 show 
HeLa cells that were transfected with YFP-DRP1 and Oct-DsRed and treated 
with 1 μM STS. Videos 3 and 4 show HeLa cells expressing YFP–SUMO-1–
positive puncta that were imaged in time-lapse microscopy to follow the 
mitochondria labeled with MitoFluor red. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200610042/DC1.
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